Release Date: 13/08/09 08:23 Summary: Share Purchase Plan and Prospectus Price Sensitive: Yes Download Document 488.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%